|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Can we further optimize therapeutic hypothermia for hypoxic-ischemic encephalopathy?显示文摘Perinatal hypoxic-ischemic encephalopathy is a leading cause of neonatal death and disability.Therapeutic hypothermia significantly reduces death and major disability associated with hypoxic-ischemic encephalopathy;however,many infants still experience lifelong disabilities to movement,sensation and cognition.Clinical guidelines,based on strong clinical and preclinical evidence,recommend therapeutic hypothermia should be started within 6 hours of birth and continued for a period of 72 hours,with a target brain temperature of 33.5 ±0.5℃ for infants with moderate to severe hypoxic-ischemic encephalopathy.The clinical guidelines also recommend that infants be re warmed at a rate of 0.5℃ per hour,but this is not based on strong evidence.There are no randomized controlled trials investigating the optimal rate of rewarming after therapeutic hypothermia for infants with hypoxic-ischemic encephalopathy.Preclinical studies of rewarming are conflicting and results were confounded by treatment with sub-optimal durations of hypothermia.In this review,we evaluate the evidence for the optimal start time,duration and depth of hypothermia,and whether the rate of rewarming after treatment affects brain injury and neurological outcomes. | Anthony Davies Guido Wassink Laura Bennet Alistair J.Gunn Joanne O.Davidson | 2019 | Neural Regeneration Research2019，14，10： | 20 |
| 2 | Evidence supporting WNT2 as an autism susceptibility gene显示文摘 | Wassink T H Piven J Vieland V J | 2001 | Ameri- can journal of medical genetics2001，105，5： | 1 |
| 3 | The metabolic syndrome: metabolic changes with vascular consequences 显示文摘 | Wassink AM Olijhoek JK Visseren FL | 2007 | Eur J Clin Invest2007，37，1： | 1 |
| 4 | Physically based modeling of reciprocating lip seal friction显示文摘 | WASSINK D B LENSS V G LEVITT J A | 2001 | ASME Journal of Tribology2001，123，2： | 1 |
| 5 | Risk of elevated resting heart rate on the development of type 2 di-abetes in patients with clinically manifest vascular diseases显示文摘 | Bemelmans RH Wassink AM van der Graaf Y | 2012 | Eur J Endocrinol2012，166，4： | 1 |
| 6 | Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovaseular disease, peripheral arterial disease or abdominal aortic aneurysm 显示文摘 | Wassink AM van der Graaf Y Olijhoek JK | 2008 | Eur Heart J2008，29，2： | 1 |
| 7 | Simultaneous determination of sulfadiazine and trime-thoprim in animal feed by liquid chromatography with UV and tandem mass spectrometric detection显示文摘 | Siska Croubels Pascal Wassink Patric De Backer | 2002 | Anal Chim Acta2002，，473： | 1 |
| 8 | Plasma triglyceride levels increase the risk for recurrent vascular events independent of LDL-eholesterol or nonHDL-cholesterol 显示文摘 | van de Woestijne AP Wassink AM Monajemi H | 2013 | Int J Cardiol2013，167，2： | 1 |
| 9 | The search for autism disease genes显示文摘 | Wassink TH Brzustowicz LM Bartlett CW | 2004 | Ment Retard Dev Disabil Res Rev2004，10，： | 1 |
| 10 | The metabolic syndrome: metabolic changes with vascular consequences显示文摘 | Wassink AM Olijhoek JK Visseren FL | 2007 | Eur J Clin Invest2007，37，1： | 1 |
| 11 | Mass transfer, fluid flow and membrane properties in flat and corrugated plate hyperfiltration mdules显示文摘 | Racz I G Wassink J G Klassen R | 1986 | Desalination1986，60，： | 1 |
| 12 | Evidence supporting WNT2 as an autism susceptibility gene显示文摘 | Wassink T H Piven J Vieland V J | 2001 | Ameri- can Journal of Medical Genetics2001，105，5： | 1 |
| 13 | Adsorption of betaines by wool and its effect oil dyeing显示文摘 | Kroezen A B J Wassink J Groot Schipper C A C | 1989 | Journal of the Society of Dyers and Colourists1989，105，11： | 1 |
| 14 | Plasma triglyceride levels increase the risk for recurrent vascular events Independent of LDL-cholesterol or nonHDL-cholesterol 显示文摘 | Van De Woestijne AP Wassink AJ Monajemi H | 2013 | Int J Cardiol2013，167，2： | 1 |
| 15 | Solvent extraction separation of zinc and cadmium from nickel and cobalt using Aliquat 336,a strong base anion exchanger,in the chloride ang thiocyanate forms显示文摘 | Berend Wassink | 2000 | Hydrometallurgy2000，，57： | 1 |
| 16 | Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism 显示文摘 | Wassink T H Hazlett H C Epping E A | 2007 | Arch Gen Psychiatry2007，64，6： | 1 |
| 17 | Evidence supporting WNT2 as an autism susceptibility gene 显示文摘 | Wassink TH Piven J Vieland VJ | 2001 | Am J Med Genet2001，105，： | 1 |
| 18 | Evidence upporting WNT2 asan autism susceptibility gene显示文摘 | Piven J Vieland VJ | 2001 | Am J Med Genet2001，105，： | 1 |
| 19 | Possible association of a cholecystokinin promoter variant to schizophrenia显示文摘 | Wang Z Wassink T Andreasen NC | 2002 | Am J Med Genet2002，114，5： | 1 |
| 20 | Sheffield VC(2002) Evaluation of FOXP2 as an autism susceptibility gene显示文摘 | Wassink TH Piven J Vieland VJ | 2002 | Am J Med Genet2002，114，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员